In a prospective study extending up to 19 years, beta cell function has been serially assessed in 25 monozygotic twins initially discordant for Type I diabetes mellitus. Currently, continuation of this prospective study is threatened because of lack of funding of a larger NIH grant of which this particular project was a small part. In this present proposal we request funds to enable us a) to continue prospective follow-up of these unique individuals to determine if they convert to immunologic abnormality or endocrine dysfunction, b) to study more twins with our new conceptual framework concerning the time course of the development of diabetes, c) to apply recently developed and ongoing immunologic techniques and correlate this with endocrine function and d) to probe the events surrounding conversion to immunological abnormality. On the basis of five of the prospectively studied monozygotic twins who developed Type I diabetes we have evidence that there is a progressive slow loss of first phase insulin release associated with immunologic abnormalities which precedes glycemic abnormalities. Our preliminary data now indicates that response to intravenous glucose is the most sensitive indicator of progressive beta cell dysfunction and we propose to concentrate on that parameter to enable us to truly define if the loss is as linear as it appears. Extended haplotype HLA typing, islet-cell antibodies (cytoplasmic and new surface), T cell activation antigens, insulin and glucagon release and at the time of immunologic conversion, multiple autoantibodies, viral titers, viral cultures and T cell analyses will be applied to better define the pathogenesis of Type I diabetes.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK033790-03
Application #
3232179
Study Section
Metabolism Study Section (MET)
Project Start
1984-04-01
Project End
1987-03-31
Budget Start
1986-04-01
Budget End
1987-03-31
Support Year
3
Fiscal Year
1986
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Pugliese, A; Solimena, M; Awdeh, Z L et al. (1993) Association of HLA-DQB1*0201 with stiff-man syndrome. J Clin Endocrinol Metab 77:1550-3
Gianani, R; Pugliese, A; Bonner-Weir, S et al. (1992) Prognostically significant heterogeneity of cytoplasmic islet cell antibodies in relatives of patients with type I diabetes. Diabetes 41:347-53
Vardi, P; Crisa, L; Jackson, R A (1991) Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients. Diabetologia 34:93-102
Ziegler, R; Alper, C A; Awdeh, Z L et al. (1991) Specific association of HLA-DR4 with increased prevalence and level of insulin autoantibodies in first-degree relatives of patients with type I diabetes. Diabetes 40:709-14
Ziegler, R; Jackson, R A; Ziegler, A G et al. (1990) Type I diabetes: polygenic inheritance, multiple autoantigens and 'dual' parameter prediction. J Autoimmun 3 Suppl 1:69-74
Ziegler, A G; Herskowitz, R D; Jackson, R A et al. (1990) Predicting type I diabetes. Diabetes Care 13:762-5
Bleich, D; Jackson, R A; Soeldner, J S et al. (1990) Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes. Diabetes Care 13:111-8
Karasik, A; O'Hara, C; Srikanta, S et al. (1989) Genetically programmed selective islet beta-cell loss in diabetic subjects with Wolfram's syndrome. Diabetes Care 12:135-8
Ziegler, A G; Ziegler, R; Vardi, P et al. (1989) Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes. Diabetes 38:1320-5